UBS shares surge as bank returns to profit following takeover of Credit Suisse
By Louis Goss
UBS on Tuesday posted a return to profit from two consecutive quarters of losses, as the Swiss bank massively outstripped analysts' forecasts while benefiting from its ongoing takeover of rival Credit Suisse.
The Swiss bank's balance sheet was boosted by the addition of $3.83 billion in revenue from Credit Suisse, following its state-backed acquisition of the financier in March 2023 which saved it from the brink of collapse.
The addition of Credit Suisse's assets, paired with UBS' own push to cut its operating expenses by $1 billion, saw the banking giant swing back into profit in the first quarter of 2024, as the increase in its revenue outpaced the increase in costs linked to its $3.2 billion takeover.
This saw UBS massively beat analysts' expectations in posting pre-tax profits worth $2.37 billion, compared to the $1.04 billion expected by 13 company watchers polled by the Swiss financier itself.
UBS (CH:UBSG) shares, listed on the SIX Swiss Exchange in Zurich, surged 8% on Tuesday having gained 52% over the previous 12 months following the bank's state-backed takeover of its main rival in March last year.
The Zurich headquartered financier reported a 46% year-on-year increase in revenue, to $12.74 billion, largely as a result of the addition of $3.83 billion in revenue from Credit Suisse, which was mainly derived from the bank's wealth management and retail divisions.
UBS' global wealth management arm saw the addition of $27 billion in new assets from the Credit Suisse takeover as the bank also benefited from taking on its rivals' clients.
This increased revenue led to a 59% surge in UBS' pre-tax operating profits, to $2.38 billion, as the increase in the Swiss bank's revenue outstripped a 42% increase in its costs, largely related to Credit Suisse's personnel.
Looking ahead, UBS warned that Switzerland's March interest rate cuts could lower net interest income from its global wealth management and personal & corporate banking divisions in the second quarter.
-Louis Goss
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-07-24 0451ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing